Twist Bioscience Corporation (TWST)
USD 37.11
(7.38%)
USD 37.11
(7.38%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 32.06 Million USD | -18.43% |
| 2022 | 39.3 Million USD | 23.61% |
| 2021 | 31.8 Million USD | 158.77% |
| 2020 | 12.28 Million USD | 67.65% |
| 2019 | 7.33 Million USD | 21.6% |
| 2018 | 6.02 Million USD | 229.94% |
| 2017 | 1.82 Million USD | 48.78% |
| 2016 | 1.22 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 28.48 Million USD | -6.23% |
| 2024 Q2 | 30.37 Million USD | -1.58% |
| 2024 Q1 | 30.86 Million USD | -3.74% |
| 2023 Q3 | 36.35 Million USD | -8.94% |
| 2023 Q4 | 32.06 Million USD | -11.8% |
| 2023 FY | 32.06 Million USD | -18.43% |
| 2023 Q1 | 44.59 Million USD | 13.46% |
| 2023 Q2 | 39.92 Million USD | -10.48% |
| 2022 Q4 | 39.3 Million USD | -8.64% |
| 2022 FY | 39.3 Million USD | 23.61% |
| 2022 Q3 | 43.02 Million USD | -3.52% |
| 2022 Q2 | 44.59 Million USD | 10.82% |
| 2022 Q1 | 40.23 Million USD | 26.54% |
| 2021 Q3 | 21.22 Million USD | 34.01% |
| 2021 Q4 | 31.8 Million USD | 49.83% |
| 2021 Q2 | 15.83 Million USD | 18.11% |
| 2021 Q1 | 13.4 Million USD | 9.11% |
| 2021 FY | 31.8 Million USD | 158.77% |
| 2020 Q2 | 10.76 Million USD | 45.15% |
| 2020 Q1 | 7.41 Million USD | 1.17% |
| 2020 FY | 12.28 Million USD | 67.65% |
| 2020 Q4 | 12.28 Million USD | -6.63% |
| 2020 Q3 | 13.16 Million USD | 22.27% |
| 2019 Q4 | 7.33 Million USD | 33.37% |
| 2019 Q3 | 5.49 Million USD | 23.53% |
| 2019 Q2 | 4.44 Million USD | -20.0% |
| 2019 FY | 7.33 Million USD | 21.6% |
| 2019 Q1 | 5.56 Million USD | -7.75% |
| 2018 Q4 | 6.02 Million USD | 41.74% |
| 2018 Q1 | - USD | -100.0% |
| 2018 FY | 6.02 Million USD | 229.94% |
| 2018 Q3 | 4.25 Million USD | 0.0% |
| 2017 Q4 | 1.82 Million USD | 0.0% |
| 2017 FY | 1.82 Million USD | 48.78% |
| 2016 FY | 1.22 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -9615.266% |
| Aspira Women's Health Inc. | 227 Thousand USD | -14024.67% |
| Biodesix, Inc. | 1.4 Million USD | -2190.214% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -2718.056% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -173363.536% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -173363.536% |
| Bionano Genomics, Inc. | 22.89 Million USD | -40.056% |
| CareDx, Inc | 19.47 Million USD | -64.671% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 7.94 Million USD | -303.714% |
| DarioHealth Corp. | 5.06 Million USD | -533.406% |
| Exact Sciences Corporation | 127.47 Million USD | 74.848% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -450.249% |
| Guardant Health, Inc. | 61.94 Million USD | 48.242% |
| ICON Public Limited Company | 1.00 USD | -3206299900.0% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 91.569% |
| Illumina, Inc. | 587 Million USD | 94.538% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -4023.662% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | -56.154% |
| MDxHealth SA | 2.77 Million USD | -1053.76% |
| 23andMe Holding Co. | 12.46 Million USD | -157.224% |
| Medpace Holdings, Inc. | 1.00 USD | -3206299900.0% |
| Myriad Genetics, Inc. | 20.1 Million USD | -59.517% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -5125.068% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -1122.442% |
| NeoGenomics, Inc. | 24.15 Million USD | -32.733% |
| Neogen Corporation | 189.26 Million USD | 83.059% |
| Inotiv, Inc. | 56.1 Million USD | 42.849% |
| Natera, Inc. | 40.75 Million USD | 21.335% |
| OpGen, Inc. | 1.00 USD | -3206299900.0% |
| OPKO Health, Inc. | 65.69 Million USD | 51.196% |
| Psychemedics Corporation | 1.00 USD | -3206299900.0% |
| Prenetics Global Limited | 3.12 Million USD | -925.433% |
| Prenetics Global Limited | 3.12 Million USD | -925.433% |
| Precipio, Inc. | 384 Thousand USD | -8249.74% |
| Personalis, Inc. | 5.66 Million USD | -466.384% |
| RadNet, Inc. | 1.00 USD | -3206299900.0% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| Sotera Health Company | 51.98 Million USD | 38.323% |
| Neuronetics, Inc. | 8.09 Million USD | -296.182% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -837.515% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -837.515% |
| Trinity Biotech plc | 19.93 Million USD | -60.854% |
| T2 Biosystems, Inc. | 4.81 Million USD | -565.346% |
| Exagen Inc. | 2.87 Million USD | -1016.789% |